Simuric is a pharmaceutical research and development contract research organization (CRO) with professional service capabilities such as large sample, multi-center clinical trial operation, data management and statistical analysis. Biopharmaceutical companies provide industry-leading integrated R&D service platforms and innovative solutions for clinical research across the full cycle. The business covers vaccine preclinical process exploration and optimization, clinical trial design and operation, clinical trial data management and statistical analysis, Listing registration services, etc. Simuric Shenzhen Stock Exchange submitted its prospectus today.
This article is reproduced from: https://www.itjuzi.com/pre-ipo?comname=%E6%80%9D%E7%9D%A6%E7%91%9E%E7%A7%91
This site is only for collection, and the copyright belongs to the original author.